Geneticancer
Geneticancer is a French nonprofit association founded in 2016 that informs, supports, and accompanies individuals and families affected by hereditary cancers (BRCA1/2 and other predispositions) through a national network of 106 volunteer ambassadors, educational content, and research funding.
- Company typePrivate
- Founded2016
- HeadquartersParis, France
- Headcount1–10
- GTM typeB2C
- OfferingServices
What Geneticancer does
Geneticancer (stylized as GenetiCancer) is a French nonprofit association (Association Loi 1901) founded in 2016 and headquartered at 169 rue Lecourbe, 75015 Paris. It is dedicated to informing, supporting, and raising awareness about hereditary and genetic cancers, with a particular focus on carriers of BRCA1, BRCA2, TP53, PALB2, ATM, PTEN, and CDH1 mutations. The organization was established by Laetitia Mendes, a BRCA mutation carrier, and is led by her as President. Its operational backbone is a network of 106 volunteer ambassadors distributed across all French regions, providing localized peer support, alongside a scientific committee anchored by senior oncogeneticists including Pr Dominique Stoppa-Lyonnet of Institut Curie.
The association's product surface is built on a standard web stack: a WordPress website with WooCommerce for e-commerce, Stripe for payment processing, and integrations for YouTube, Wistia, Google Analytics, Google reCAPTCHA, and Complianz. Core offerings include three illustrated information brochures covering genetic testing, family communication, and risk-reducing surgeries; a genetic risk self-assessment questionnaire; an educational video series ("L'oncogénétique en 3 minutes"); a personal health companion tool called My Genetibook; a #mygeneticstory testimonial platform; and an e-shop selling solidarity merchandise such as books, teddy bears, tote-bags, caps, and gala tickets.
Geneticancer is primarily a donation-funded nonprofit. Its revenue model rests on three streams: tax-deductible individual donations (66% deduction up to 20% of taxable income for French taxpayers, enabled by its "Association d'intérêt général" status since September 2017), e-commerce sales of solidarity products, and recurring annual membership fees. The association also runs events — solidarity races, conferences, roundtables, galas — as both awareness and fundraising vehicles. A 2021 solidarity race mobilized over 1,100 participants and generated 6,800 euros, with 7,000 euros subsequently directed to the GENEPSO national research study. Distribution is omnichannel: the website and e-shop, an active Instagram presence, YouTube video content, email newsletters, regional ambassadors, in-person events, and earned media coverage across major French outlets including TF1, M6, France 2, BFM TV, RTL, and Europe 1, as well as women's press such as Gala, Elle, and Marie-Claire.
Geneticancer firmographics
Firmographics- Name
- Geneticancer
- Legal name
- GENETICANCER
- Website
- https://geneticancer.org
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Geneticancer is a French nonprofit association founded in 2016 that informs, supports, and accompanies individuals and families affected by hereditary cancers (BRCA1/2 and other predispositions) through a national network of 106 volunteer ambassadors, educational content, and research funding.
- Ownership category
- akta.pro rank
Where Geneticancer is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
Geneticancer business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Donations: The association receives donations from the public, which are tax-deductible at 66% up to 20% of taxable income for French taxpayers. Donations fund research, prevention actions, and patient/family support.
- E-commerce Sales: Sale of solidarity products including the book by Laetitia Mendes, teddys (adults and children), tote-bags, caps, and gala tickets. These goods are marketed to finance genetic cancer research projects.
- Membership Adhesions: Annual membership fees for supporters wishing to join the association and contribute to its mission.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Solidarity products including teddys (adults and children), tote-bags, caps, and books |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels8 records
Geneticancer product offering
Product offeringCore offering
Geneticancer is a French nonprofit association (Loi 1901) that informs, supports, and raises awareness about genetic and hereditary cancers. It delivers educational resources (brochures, videos, self-assessment questionnaires), a personal health companion tool (My Genetibook), a nationwide network of 106 regional volunteer ambassadors, and funds genetic cancer research. The association also sells solidarity merchandise and accepts tax-deductible donations to support its mission.
Product overview
Geneticancer is a non-profit association (Loi 1901) focused on preventing genetic and hereditary cancers. The organization offers a combination of information resources (brochures, videos, self-assessment questionnaires), digital tools (My Genetibook), an e-commerce platform for solidarity merchandise, and donation/membership services. Core offerings include educational content explaining oncogenetics, a network of regional ambassadors providing support, and funding for research projects. The association's digital ecosystem is built on WordPress with WooCommerce for e-commerce and Stripe for secure payment processing.
Differentiator
Problem solved
Functional benefit
Products and services
- My Genetibook
Quantifiable outcome
- Supported thousands of families across France with genetic cancer risk
- +2 more outcomes
Companies that use Geneticancer
Customer profileNamed customers10 records
Segments4 records
Ideal customer profiles4 records
Geneticancer technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration8 records
Geneticancer partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and minor.
- Comité du Rhône de La Ligue contre le cancercorePartnership for the May 2025 conference on genetic cancers in Lyon, bringing together healthcare professionals, patients, and relatives for two roundtables on genetic testing communication and prevention.
- Syndrome de Lynch FrancecoreCo-organization of the May 2025 Lyon conference on genetic cancers, specifically addressing Lynch syndrome alongside BRCA and other hereditary cancer syndromes.
- Clovis OncologyminorPharmaceutical laboratory collaborated with IMAGYN (association of gynecological cancer patients) to publish a booklet on PARP inhibitor treatments for ovarian cancer patients.
- IMAGYN (Association de patientes atteintes de cancers gynécologiques)minorAssociation of gynecological cancer patients collaborated with Clovis Oncology to create educational materials on PARP inhibitors for ovarian cancer care.
- Pr Dominique Stoppa-Lyonnet (Institut Curie, Paris)minorHead of oncogenetics department at Institut Curie, member of Geneticancer's scientific council providing research expertise.
- GENEPSO (Gène Étude Prospective Sein Ovaire)coreNational research study directed by Dr. Catherine Noguès since 1999, aiming to identify modifying factors for breast and ovarian cancer risks in BRCA1/BRCA2 mutation carriers. Geneticancer contributed 7,000 euros to support this research.
- Pr Pierre Pujol (CHRU de Montpellier)minorOncogeneticist at CHU Montpellier quoted regarding new European recommendations for expanded BRCA1/2 testing eligibility.
- French Tax Authority (DGFiP)coreOfficial recognition as 'Association d'intérêt général à caractère social' under articles 200 and 238 bis of the French General Tax Code, enabling tax-deductible donations.
Scale indicators7 records
Recent moves8 records
Expansion highlights5 records
Geneticancer competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Geneticancer social profiles
Digital presenceGeneticancer financial estimates
Financial estimateRevenue estimate
Valuation estimate
Geneticancer leadership team
Management profileNumber of profiles
Profiles2 records
Geneticancer funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Geneticancer M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Geneticancer
What does Geneticancer do?
Geneticancer is a French nonprofit association (Loi 1901) that informs, supports, and raises awareness about genetic and hereditary cancers. It delivers educational resources (brochures, videos, self-assessment questionnaires), a personal health companion tool (My Genetibook), a nationwide network of 106 regional volunteer ambassadors, and funds genetic cancer research. The association also sells solidarity merchandise and accepts tax-deductible donations to support its mission.
Is Geneticancer a public or private company?
Geneticancer is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Geneticancer founded?
Geneticancer was founded in 2016. It employs 1 to 10 people.
Where is Geneticancer based?
Geneticancer is headquartered in Paris, France, in the Europe region.
How does Geneticancer make money?
Three revenue lines are on record. Donations are the primary driver. The others are E-commerce Sales and membership Adhesions.
Does Geneticancer have an API?
No public API is recorded for Geneticancer.